Coumarin-based Strategies for Breast Cancer: A Multifaceted Perspective

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Organic Chemistry

Background:

• Breast cancer is a leading global health concern for women.
• Current therapies face challenges of toxicity and drug resistance.
• There is a critical need for novel, safer, and more effective breast cancer treatments.

Purpose of the Study:

• To review coumarin-based compounds for breast cancer therapy.
• To analyze design strategies, mechanisms of action, and structure-activity relationships (SAR).
• To explore molecular docking studies of coumarin derivatives against key cancer-related enzymes.

Main Methods:

• Comprehensive literature review of 18 reported coumarin-based compounds.
• Analysis of molecular docking simulations targeting tyrosine kinases, topoisomerases, and serine/threonine kinases.
• Correlation of ligand-protein interactions with experimental anticancer activities.

Main Results:

• Specific substitutions at the 3- and 6-positions of the coumarin scaffold significantly influence target binding.
• Key interactions such as hydrogen bonding, van der Waals forces, and hydrophobic contacts are crucial for stabilizing ligand-protein complexes.
• Experimental anticancer activities were found to correlate with these molecular interactions.

Conclusions:

• Coumarin derivatives represent a promising scaffold for developing new anticancer drugs.
• Rational drug design based on SAR and molecular interactions can enhance efficacy and selectivity.
• Further research into coumarin-based compounds could lead to improved breast cancer therapeutics.